1. Home
  2. GDTC vs WKEY Comparison

GDTC vs WKEY Comparison

Compare GDTC & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • WKEY
  • Stock Information
  • Founded
  • GDTC 2018
  • WKEY 1999
  • Country
  • GDTC Singapore
  • WKEY Switzerland
  • Employees
  • GDTC N/A
  • WKEY N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • WKEY EDP Services
  • Sector
  • GDTC Health Care
  • WKEY Technology
  • Exchange
  • GDTC Nasdaq
  • WKEY Nasdaq
  • Market Cap
  • GDTC 23.7M
  • WKEY 21.5M
  • IPO Year
  • GDTC 2023
  • WKEY N/A
  • Fundamental
  • Price
  • GDTC $2.13
  • WKEY $2.15
  • Analyst Decision
  • GDTC Buy
  • WKEY Strong Buy
  • Analyst Count
  • GDTC 1
  • WKEY 1
  • Target Price
  • GDTC $5.00
  • WKEY $4.00
  • AVG Volume (30 Days)
  • GDTC 12.4K
  • WKEY 31.5K
  • Earning Date
  • GDTC 01-01-0001
  • WKEY 09-30-2024
  • Dividend Yield
  • GDTC N/A
  • WKEY N/A
  • EPS Growth
  • GDTC N/A
  • WKEY N/A
  • EPS
  • GDTC N/A
  • WKEY N/A
  • Revenue
  • GDTC $330,254.00
  • WKEY $20,985,000.00
  • Revenue This Year
  • GDTC $4.46
  • WKEY N/A
  • Revenue Next Year
  • GDTC N/A
  • WKEY $81.73
  • P/E Ratio
  • GDTC N/A
  • WKEY N/A
  • Revenue Growth
  • GDTC N/A
  • WKEY N/A
  • 52 Week Low
  • GDTC $1.20
  • WKEY $1.35
  • 52 Week High
  • GDTC $5.50
  • WKEY $3.44
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 69.51
  • WKEY 46.57
  • Support Level
  • GDTC $1.96
  • WKEY $2.07
  • Resistance Level
  • GDTC $2.16
  • WKEY $2.30
  • Average True Range (ATR)
  • GDTC 0.15
  • WKEY 0.15
  • MACD
  • GDTC 0.03
  • WKEY -0.01
  • Stochastic Oscillator
  • GDTC 84.07
  • WKEY 25.00

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

Share on Social Networks: